SG11201503637SA - Methods and devices for the treatment of ocular diseases in human subjects - Google Patents

Methods and devices for the treatment of ocular diseases in human subjects

Info

Publication number
SG11201503637SA
SG11201503637SA SG11201503637SA SG11201503637SA SG11201503637SA SG 11201503637S A SG11201503637S A SG 11201503637SA SG 11201503637S A SG11201503637S A SG 11201503637SA SG 11201503637S A SG11201503637S A SG 11201503637SA SG 11201503637S A SG11201503637S A SG 11201503637SA
Authority
SG
Singapore
Prior art keywords
treatment
methods
devices
human subjects
ocular diseases
Prior art date
Application number
SG11201503637SA
Other languages
English (en)
Inventor
Vladimir Zarnitsyn
Samirkumar Patel
Daniel White
Glenn Noronha
Brian Burke
Original Assignee
Clearside Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clearside Biomedical Inc filed Critical Clearside Biomedical Inc
Publication of SG11201503637SA publication Critical patent/SG11201503637SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
SG11201503637SA 2012-11-08 2013-11-08 Methods and devices for the treatment of ocular diseases in human subjects SG11201503637SA (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261724144P 2012-11-08 2012-11-08
US201261734872P 2012-12-07 2012-12-07
US201261745237P 2012-12-21 2012-12-21
US201361773124P 2013-03-05 2013-03-05
US201361785229P 2013-03-14 2013-03-14
US201361819388P 2013-05-03 2013-05-03
US201361873660P 2013-09-04 2013-09-04
US201361898926P 2013-11-01 2013-11-01
PCT/US2013/069156 WO2014074823A1 (fr) 2012-11-08 2013-11-08 Procédés et dispositifs pour le traitement de maladies oculaires chez des sujets humains

Publications (1)

Publication Number Publication Date
SG11201503637SA true SG11201503637SA (en) 2015-06-29

Family

ID=50685178

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503637SA SG11201503637SA (en) 2012-11-08 2013-11-08 Methods and devices for the treatment of ocular diseases in human subjects

Country Status (16)

Country Link
US (10) US20150258120A1 (fr)
EP (2) EP3721872A1 (fr)
JP (4) JP6487848B2 (fr)
KR (3) KR20210133321A (fr)
CN (2) CN104884049A (fr)
AU (2) AU2013342275B2 (fr)
BR (1) BR112015010566A2 (fr)
CA (3) CA2890471C (fr)
EA (1) EA034963B1 (fr)
ES (1) ES2813869T3 (fr)
HK (1) HK1213192A1 (fr)
IL (1) IL238432B (fr)
MX (2) MX2020005126A (fr)
PH (1) PH12015500986A1 (fr)
SG (1) SG11201503637SA (fr)
WO (1) WO2014074823A1 (fr)

Families Citing this family (174)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2419610C2 (ru) 2005-05-26 2011-05-27 Ньюрон Системз, Инк. Композиции и способы лечения заболевания сетчатки
KR20180030264A (ko) 2005-11-23 2018-03-21 악셀레론 파마 인코포레이티드 액티빈-ａｃｔｒⅱａ 길항제 및 골 성장을 촉진하기 위한 이들의 용도
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
MX2008012991A (es) 2006-04-07 2008-10-17 Procter & Gamble Anticuerpos que ligan proteina tirosina fosfatasa humana beta (hptpbeta) y los usos de estos.
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
JP5237970B2 (ja) 2007-02-01 2013-07-17 アクセルロン ファーマ， インコーポレイテッド 乳癌を治療または予防するためのアクチビンＡｃｔＲＩＩａアンタゴニストおよび使用
TW201940502A (zh) 2007-02-02 2019-10-16 美商艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
TWI459963B (zh) 2007-02-09 2014-11-11 Acceleron Pharma Inc 包含ActRIIa-Fc融合蛋白的醫藥組合物；ActRIIa-Fc融合蛋白於治療或預防與癌症相關的骨質流失之用途；ActRIIa-Fc融合蛋白於治療或預防多發性骨髓瘤之用途
CN103877564A (zh) 2007-09-18 2014-06-25 阿塞勒隆制药公司 活化素-actriia拮抗剂和减少或抑制fsh分泌的用途
LT3750552T (lt) 2008-08-14 2023-06-26 Acceleron Pharma Inc. Gdf gaudyklės
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
KR20210034684A (ko) 2009-06-12 2021-03-30 악셀레론 파마 인코포레이티드 절두된 ＡｃｔＲＩＩＢ-ＦＣ 융합 단백질
RU2519123C2 (ru) 2009-07-06 2014-06-10 Аэрпио Терапьютикс Инк. Соединения, композиции и способы предупреждения метастазов раковых клеток
JP6267425B2 (ja) 2009-11-17 2018-01-24 アクセルロン ファーマ， インコーポレイテッド 筋ジストロフィー治療のためのユートロフィン誘導に関するａｃｔｒｉｉｂタンパク質およびその改変体およびその使用
JP5885670B2 (ja) 2009-12-11 2016-03-15 アルデイラ セラピューティクス， インコーポレイテッド 黄斑変性の処置のための組成物および方法
EP2600901B1 (fr) 2010-08-06 2019-03-27 ModernaTX, Inc. Compositions pharmaceutiques a base d'acides nucléiques modifiés et leur utilisation medicale
DE19177059T1 (de) 2010-10-01 2021-10-07 Modernatx, Inc. N1-methyl-pseudouracile enthältendes ribonucleinsäuren sowie ihre verwendungen
CN104758118B (zh) 2010-10-15 2018-04-06 科尼尔赛德生物医学公司 用于进入眼睛的装置
US20120121576A1 (en) 2010-11-08 2012-05-17 Jasbir Seehra Actriia binding agents and uses thereof
WO2012135805A2 (fr) 2011-03-31 2012-10-04 modeRNA Therapeutics Administration et formulation d'acides nucléiques génétiquement modifiés
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
LT3682905T (lt) 2011-10-03 2022-02-25 Modernatx, Inc. Modifikuoti nukleozidai, nukleotidai ir nukleorūgštys bei jų naudojimas
CN104039351A (zh) 2011-10-13 2014-09-10 阿尔皮奥治疗学股份有限公司 用于治疗血管渗漏综合征和癌症的方法
PL2791160T3 (pl) 2011-12-16 2022-06-20 Modernatx, Inc. Kompozycje zmodyfikowanego mrna
DE18200782T1 (de) 2012-04-02 2021-10-21 Modernatx, Inc. Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
AU2013337677B2 (en) 2012-11-02 2018-06-28 Celgene Corporation Activin-ActRII antagonists and uses for treating bone and other disorders
KR20210133321A (ko) 2012-11-08 2021-11-05 클리어사이드 바이오메디컬, 인코포레이드 인간 대상체에서 안구 질병을 치료하기 위한 방법 및 장치
RS63237B1 (sr) 2012-11-26 2022-06-30 Modernatx Inc Terminalno modifikovana rnk
SG11201505389WA (en) * 2013-01-18 2015-08-28 Advenchen Pharmaceuticals Llc Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline
KR102435676B1 (ko) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US20150050277A1 (en) 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
CA3121759C (fr) 2013-05-03 2024-01-02 Clearside Biomedical, Inc. Appareil et methodes d'injection oculaire
US20160114039A1 (en) * 2013-05-24 2016-04-28 Bayer Healthcare Llc Treatment of polypoidal choroidal vasculopathy
EP3003454B1 (fr) 2013-06-03 2020-01-08 Clearside Biomedical, Inc. Appareil pour une administration de médicament à l'aide de multiples réservoirs
WO2014203182A1 (fr) * 2013-06-20 2014-12-24 Novartis Ag Utilisation d'un antagoniste du vegf dans le traitement de la néovascularisation choroïdienne
USD756524S1 (en) * 2013-08-05 2016-05-17 Xialing Zhang Protective cover for a subdermal needle electrode cable assembly
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
EA201690675A1 (ru) 2013-10-03 2016-08-31 Модерна Терапьютикс, Инк. Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
KR101660370B1 (ko) 2013-12-12 2016-09-27 삼성메디슨 주식회사 초음파 영상 표시 방법 및 장치
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
MX2016009312A (es) * 2014-01-16 2017-01-06 Ontogenesis Llc Composiciones y metodos para el tratamiento de la neovascularizacion y/o fuga intraocular.
JP6548229B2 (ja) 2014-02-12 2019-07-24 オービット・バイオメディカル・リミテッドＯｒｂｉｔ Ｂｉｏｍｅｄｉｃａｌ Ｌｉｍｉｔｅｄ 治療薬の脈絡膜上投与のための方法及び装置
CN106456614A (zh) 2014-03-14 2017-02-22 爱尔皮奥治疗有限公司 HPTP‑β抑制剂
EP3145532A4 (fr) * 2014-05-02 2018-02-21 Mayo Foundation for Medical Education and Research Traitement individualisé d'une maladie de l' oeil
US9949874B2 (en) 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
US9925088B2 (en) 2014-06-06 2018-03-27 Janssen Biotech, Inc. Sub-retinal tangential needle catheter guide and introducer
BR112016029226A2 (pt) 2014-06-13 2017-10-17 Acceleron Pharma Inc métodos e composições para o tratamento de úlceras
WO2015195842A1 (fr) * 2014-06-17 2015-12-23 Clearside Biomedical, Inc. Procédés et dispositifs de traitement de troubles oculaires postérieurs
MX2016017028A (es) 2014-06-20 2017-08-07 Clearside Biomedical Inc Canula de diametro variable y metodos para el control de la profundidad de insercion para administracion de medicamentos.
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
CA3200870A1 (fr) * 2014-07-30 2016-02-04 Massachusetts Eye And Ear Infirmary Methotrexate pour le traitement de la vitreoretinopathie proliferante
US10219936B2 (en) 2014-09-11 2019-03-05 Orbit Biomedical Limited Therapeutic agent delivery device with advanceable cannula and needle
US10258502B2 (en) 2014-09-18 2019-04-16 Orbit Biomedical Limited Therapeutic agent delivery device
KR20170082594A (ko) 2014-11-10 2017-07-14 에프. 호프만-라 로슈 아게 항-ang2 항체 및 사용 방법
CN107074941A (zh) 2014-11-10 2017-08-18 豪夫迈·罗氏有限公司 双特异性抗体和用于眼科学的方法
RU2017120361A (ru) * 2014-11-10 2018-12-13 Ф.Хоффманн-Ля Рош Аг Антитела к pdgf-b и способы их применения
BR112017009817A2 (pt) 2014-11-10 2018-02-14 Hoffmann La Roche anticorpos anti-il-1beta e métodos de utilização
WO2016093299A1 (fr) * 2014-12-10 2016-06-16 千寿製薬株式会社 Agent liquide aqueux
TWI597051B (zh) * 2015-04-16 2017-09-01 林伯剛 高半胱胺酸用於偵測及診斷人類眼部之息肉狀脈絡膜血管病變的用途及方法
TWI773641B (zh) * 2015-05-08 2022-08-11 日商活效製藥股份有限公司 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑
ES2971096T3 (es) * 2015-06-06 2024-06-03 Cloudbreak Therapeutics Llc Composiciones y métodos para tratar el terigio
EP3103491A1 (fr) * 2015-06-10 2016-12-14 Sanofi-Aventis Deutschland GmbH Dispositif de capteur destiné à être fixé à un dispositif d'administration de médicament
KR101778004B1 (ko) * 2015-06-22 2017-09-15 (주) 에빅스젠 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물
TWI664965B (zh) 2015-06-22 2019-07-11 新源生物科技股份有限公司 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法
WO2016209972A1 (fr) * 2015-06-26 2016-12-29 Amgen Inc. Biomarqueur de survie dans le traitement d'un carcinome à cellules rénales avec un inhibiteur de vegfr et un inhibiteur d'ang2
EP3324944A4 (fr) * 2015-07-23 2019-04-03 Aerie Pharmaceuticals, Inc. Systèmes d'administration de médicaments intravitréens pour le traitement d'états oculaires
CA3119498A1 (fr) * 2015-07-31 2017-02-09 Medimmune Limited Methodes de traitement de troubles medies par l'hepcidine
CN118724806A (zh) 2015-08-21 2024-10-01 奥尔德拉医疗公司 氘化化合物和其用途
KR20180054677A (ko) 2015-09-23 2018-05-24 에르피오 세러퓨틱스 인코포레이티드 Tie-2의 활성화제로 안내압을 치료하는 방법
JP2018534930A (ja) * 2015-10-30 2018-11-29 ジェネンテック， インコーポレイテッド 抗ｄ因子抗体及びコンジュゲート
CN108295072A (zh) * 2015-12-09 2018-07-20 瑞阳(苏州)生物科技有限公司 尼达尼布防治眼部疾病的用途
ES2972329T3 (es) * 2015-12-17 2024-06-12 Link Genomics Inc Supresor de neovascularización coroidea o supresor de formación de drusas y método para evaluar o detectar las mismas
CN105496957A (zh) * 2015-12-22 2016-04-20 中山大学中山眼科中心 一种吡非尼酮缓释滴眼液
EP3397276A4 (fr) 2015-12-30 2019-12-18 Kodiak Sciences Inc. Anticorps et conjugués de ceux-ci
AU2017206114A1 (en) * 2016-01-08 2018-08-02 Clearside Biomedical, Inc. Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
WO2017120600A1 (fr) * 2016-01-08 2017-07-13 Clearside Biomedical, Inc. Compositions et méthodes de traitement de la dégénérescence maculaire humide liée à l'âge
BR112018014467A2 (pt) * 2016-02-04 2018-12-11 Ni Jinsong tecnologia de sinergismo fármaco-anticorpo para o tratamento de doenças
WO2017147617A1 (fr) 2016-02-28 2017-08-31 Aldeyra Therapeutics, Inc. Traitement des pathologies oculaires allergiques avec des cyclodextrines
US10478553B2 (en) 2016-03-09 2019-11-19 Orbit Biomedical Limited Apparatus for subretinal administration of therapeutic agent via a curved needle
SG11201807523PA (en) * 2016-03-10 2018-09-27 Viela Bio Inc Ilt7 binding molecules and methods of using the same
WO2017165449A1 (fr) * 2016-03-22 2017-09-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Hydrogel thermoréactif contenant des microparticules de polymère pour l'administration biologique oculaire non invasive
KR20230130765A (ko) 2016-04-15 2023-09-12 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 습성 연령 관련 황반 변성의 치료를 위한 조성물
CA3062845A1 (fr) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systemes et methodes pour l'administration de medicaments par voie ophtalmique
AU2017264697A1 (en) * 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
KR102496234B1 (ko) * 2016-06-02 2023-02-06 에이디에스 테라퓨틱스 엘엘씨 녹내장 수술 성공을 개선하기 위해 닌테다닙을 사용하는 조성물 및 방법
US11000410B2 (en) 2016-06-17 2021-05-11 Gyroscope Therapeutics Limited Guide apparatus for tangential entry into suprachoroidal space
US10646374B2 (en) 2016-06-17 2020-05-12 Orbit Biomedical Limited Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
US10806629B2 (en) 2016-06-17 2020-10-20 Gyroscope Therapeutics Limited Injection device for subretinal delivery of therapeutic agent
CA3030298A1 (fr) 2016-07-20 2018-01-25 Aerpio Therapeutics, Inc. Anticorps monoclonaux humanises ciblant ve-ptp (hptp-ss)
US11278546B2 (en) * 2016-07-22 2022-03-22 Aiviva Biopharma, Inc. Multikinase inhibitors and uses in ocular fibrosis
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
EP3515444A4 (fr) 2016-09-26 2020-06-03 Reyoung (Suzhou) Biology Science & Technology Co., Ltd Composition destinée au traitement de maladies oculaires, et méthodes d'utilisation et procédés de fabrication
KR20190134591A (ko) * 2016-12-15 2019-12-04 프로젠 피지500 시리즈 피티와이 리미티드 조성물 및 그의 용도
EP3554582A4 (fr) 2016-12-16 2020-06-24 The Brigham and Women's Hospital, Inc. Système et procédé de pénétration médicale autorégulée, dépendant de la résistance
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
SG10201912128SA (en) 2017-02-01 2020-02-27 Univ Yale Treatment of diuretic resistance
WO2018162271A1 (fr) * 2017-03-05 2018-09-13 Rita Dobmeyer Nanoparticules pour le traitement de la dégénérescence maculaire
US11076984B2 (en) 2017-03-13 2021-08-03 Gyroscope Therapeutics Limited Method of performing subretinal drainage and agent delivery
WO2018170476A1 (fr) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Composés polymorphes et leurs utilisations
RU2643955C1 (ru) * 2017-04-19 2018-02-06 Галина Мэлсовна Чернакова Способ отбора и подготовки пробы клеток конъюнктивы для проведения бактериологического, вирусологического и иммунологического исследований
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
EP3622088A4 (fr) * 2017-05-08 2021-04-14 Hadasit Medical Research Services&Development Ltd. Biomarqueur pour thérapie anti-tnf dans des maladies rétiniennes
CA3065474A1 (fr) * 2017-05-30 2018-12-06 Eximore Ltd. Compositions et procedes de traitement du syndrome de la keratoconjonctivite seche par administration d'un antibiotique macrolide
US11786607B2 (en) 2017-06-15 2023-10-17 Modernatx, Inc. RNA formulations
AU2018302022A1 (en) * 2017-07-17 2020-02-27 Macregen, Inc. Topical delivery of therapeutic agents comprising cell-penetrating peptides for use for the treatment of age-related macular degeneration and other eye diseases
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
CN111343970A (zh) 2017-09-13 2020-06-26 北卡罗莱纳州立大学 微针贴片局部诱导脂肪组织褐变治疗肥胖症
BR112020004983A2 (pt) * 2017-09-15 2020-09-15 Oxular Limited dispositivo de canulação para administrar um agente ativo que contém composição a um olho, método para o tratamento de uma doença ou afecção pela entrega de um material líquido ou semissólido para a região afetada, método para o tratamento de uma doença ou afecção ocular por meio da injeção de um material sólido ou semissólido para o espaço supracoroide ou espaço supraciliar e método para a injeção de um materiço supracoroide ou espaço supraciliar pelo uso do dispositivoal no espa
US11883541B2 (en) 2017-10-02 2024-01-30 The Johns Hopkins University Nonviral gene transfer to the suprachoroidal space
US11040039B2 (en) 2017-10-10 2021-06-22 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
CN107815453B (zh) * 2017-10-23 2020-08-07 中山大学中山眼科中心 一种核酸适配子及其用途
CA3083743C (fr) 2017-11-29 2023-09-26 Copernicus Therapeutics, Inc. Therapie genique pour l'amelioration des fonctions oculaires
BR112020012523A2 (pt) * 2017-12-21 2020-11-24 F. Hoffmann-La Roche Ag diagnóstico complementar para antagonistas de rna htra1
WO2019136133A1 (fr) * 2018-01-03 2019-07-11 The Trustees Of Columbia University In The City Of New York Micro-aiguille pour l'administration locale d'un agent thérapeutique
WO2019136312A1 (fr) 2018-01-05 2019-07-11 Corvidia Therapeutics, Inc. Méthodes de traitement d'une inflammation médiée par il-6 sans immunosuppression
US20200345637A1 (en) * 2018-01-19 2020-11-05 Aiviva Biopharma, Inc. Suspension compositions of multi-target inhibitors
US11524053B2 (en) 2018-01-26 2022-12-13 The Regents Of The University Of California Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
WO2019161272A1 (fr) 2018-02-15 2019-08-22 North Carolina State University Synthèse de microsphères, nanosphères et structures de carbone par carbonisation hydrothermique
AU2019227997A1 (en) 2018-03-02 2020-09-24 Kodiak Sciences Inc. IL-6 antibodies and fusion constructs and conjugates thereof
CN108452309B (zh) * 2018-03-05 2019-08-23 佳木斯大学附属第一医院 一种用于预防或治疗视神经炎的药物组合物及其制备方法
CN118078205A (zh) * 2018-04-18 2024-05-28 株式会社尼康 图像处理方法、存储介质及图像处理装置
US20210236336A1 (en) * 2018-05-09 2021-08-05 North Carolina State University Applicator for corneal therapeutics
WO2020028667A1 (fr) * 2018-08-01 2020-02-06 Nanoneuron Therapeutics, Inc. Compositions neuroprotectrices et utilisation associée
JP2021533154A (ja) 2018-08-06 2021-12-02 アルデイラ セラピューティクス， インコーポレイテッド 多形化合物およびその使用
US20200061157A1 (en) * 2018-08-21 2020-02-27 California Institute Of Technology Non-leaking or minimally-leaking choroidal or retinal revascularization
CN109187987B (zh) * 2018-08-23 2021-05-11 中国人民解放军第三0九医院 Ms4a3蛋白作为标志物在诊断活动性结核病中的应用
CN113271926A (zh) 2018-09-20 2021-08-17 摩登纳特斯有限公司 脂质纳米颗粒的制备及其施用方法
CN113056353B (zh) 2018-09-25 2022-11-01 奥尔德拉医疗公司 用于治疗干眼病的调配物
CN109172128A (zh) * 2018-09-28 2019-01-11 宜邻医疗科技（上海）有限公司 一种用于细胞和基因药物注入治疗的精准注射系统
CN110840893A (zh) * 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途
AU2019417161B2 (en) * 2018-12-27 2023-06-15 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
CN109799216B (zh) * 2018-12-29 2021-11-12 佛山科学技术学院 一种基于吲哚箐绿纳米的荧光oct双模成像方法和装置
EP3920950A1 (fr) 2019-02-08 2021-12-15 CureVac AG Arn codant administré dans l'espace suprachoroïdien pour le traitement de maladies ophtalmiques
WO2020198064A1 (fr) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Formulations ophtalmiques et leurs utilisations
WO2020210368A1 (fr) * 2019-04-08 2020-10-15 Biocryst Pharmaceuticals, Inc. Inhibiteurs de la kallicréine plasmatique et leurs procédés d'utilisation dans des troubles oculaires
CN114206348A (zh) * 2019-04-16 2022-03-18 科尼尔赛德生物医学公司 可注射曲安奈德配制品
AU2020264969A1 (en) 2019-04-29 2021-12-09 EyePoint Pharmaceuticals, Inc. Tie-2 activators targeting the schlemm's canal
CN109999032A (zh) * 2019-04-30 2019-07-12 南昌大学 雷帕霉素在制备降眼内压的局部滴眼给药药物中的应用
WO2020223717A1 (fr) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Procédé de préparation d'un piégeur d'aldéhyde et d'intermédiaires
CA3137301A1 (fr) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Composes polymorphes et leurs utilisations
WO2020227341A1 (fr) * 2019-05-06 2020-11-12 9 Meters Biopharma, Inc. Compositions et procédés de traitement du syndrome de sjögren
EP3773558B1 (fr) * 2019-05-10 2022-06-15 SynAct Pharma ApS Traitement combiné d'une maladie arthritique
EP3976106A4 (fr) * 2019-05-31 2023-01-11 DOSE Medical Corporation Implants vertébraux en polyester bioérodable et procédés d'utilisation associés
WO2021051003A1 (fr) 2019-09-13 2021-03-18 Aldeyra Therapeutics, Inc. Formulations ophtalmiques de méthotrexate
WO2021072265A1 (fr) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Procédés de traitement d'un trouble oculaire
IL293131A (en) 2019-11-25 2022-07-01 Univ California Long-acting vegf inhibitors for intraocular neovascularization
EP3886858B1 (fr) * 2019-12-19 2022-05-11 Active Biotech AB Composés pour le traitement de maladies des yeux associées à une vascularisation excessive
EP4087542A4 (fr) * 2020-01-06 2023-12-20 Shilpa Medicare Limited Suspension injectable à libération prolongée de fingolimod
JP7451732B2 (ja) 2020-02-06 2024-03-18 オキュラ セラピューティクス，インコーポレイテッド 眼疾患を治療するための組成物及び方法
CA3171479A1 (fr) * 2020-02-19 2021-08-26 Clearside Biomedical, Inc. Compositions comprenant de l'axitinib et methodes de traitement de troubles oculaires
EP4252725A3 (fr) 2020-03-25 2023-11-22 Ocular Therapeutix, Inc. Implant oculaire contenant un inhibiteur de la tyrosine kinase
AU2021268026A1 (en) 2020-05-08 2023-01-19 Regeneron Pharmaceuticals, Inc. VEGF traps and mini-traps and methods for treating ocular disorders and cancer
WO2021231792A1 (fr) 2020-05-13 2021-11-18 Aldeyra Therapeutics, Inc. Formulations pharmaceutiques et leurs utilisations
CN116370408A (zh) * 2020-06-17 2023-07-04 成都瑞沐生物医药科技有限公司 一种滴眼给药治疗黄斑水肿、视神经炎和非感染性眼内炎的眼用制剂
EP4282402A1 (fr) * 2021-01-22 2023-11-29 Chengdu Ruimu Biopharmaceuticals Co., Ltd. Préparation ophtalmique pour le traitement de l'?dème maculaire, de la névrite optique et de l'endophtalmite non infectieuse par administration de gouttes oculaires
US20240199752A1 (en) * 2021-04-23 2024-06-20 Kirk William Johnson Treatment of ophthalmic diseases
WO2023004072A1 (fr) * 2021-07-21 2023-01-26 Slbst Pharma, Inc. Formulations d'hydroxychloroquine, formes posologiques et procédés d'utilisation
WO2023039168A1 (fr) * 2021-09-09 2023-03-16 The Board Of Trustees Of The Leland Stanford Junior University Utilisation de la vertéporfine pour moduler la cicatrisation de plaies après une intervention chirurgicale oculaire ou une lésion oculaire
EP4147709A1 (fr) * 2021-09-14 2023-03-15 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth Composition comprenant de l'il-36 et/ou de l'il-18 pour une utilisation dans le traitement de troubles oculaires
CN114134195B (zh) * 2021-11-03 2024-06-11 南方科技大学 预防前列腺癌的药剂的筛选方法、硝唑尼特在制药中的应用
CN114099515A (zh) * 2021-12-27 2022-03-01 中山大学中山眼科中心 氨甲蝶呤在制备治疗视网膜色素变性的药物方面的应用
USD1037439S1 (en) 2022-01-17 2024-07-30 EyePoint Pharamaceuticals, Inc. Ocular injector
US20230233455A1 (en) * 2022-01-24 2023-07-27 Celanese Eva Performance Polymers Llc Method for Prohibiting and/or Treating an Eye Condition
WO2023220136A1 (fr) * 2022-05-10 2023-11-16 The Regents Of The University Of California Acide zolédronique à dosage ultra faible pour le traitement d'une maladie rétinienne
WO2024044745A2 (fr) * 2022-08-26 2024-02-29 Asclepix Therapeutics, Inc. Formulations pour l'administration intraoculaire de peptides dérivés du collagène de type iv
CN117100845A (zh) * 2022-10-24 2023-11-24 景泽生物医药(合肥)股份有限公司 重组人奥克纤溶酶在制备治疗脉络膜血管疾病药物中的用途
US11911385B1 (en) 2022-12-14 2024-02-27 Aldeyra Therapeutics, Inc. Methotrexate treatment methods
CN117224314B (zh) * 2023-08-28 2024-04-26 叶绿体(北京)生物医药有限公司 一种可降解式自密封眼球给药微针及其制备方法与应用

Family Cites Families (380)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2008700A (en) 1930-05-12 1935-07-23 Jr John Hays Hammond Reediting of talking films
US2187259A (en) 1936-07-11 1940-01-16 George E Barnhart Hypodermic needle
US2841145A (en) 1956-05-07 1958-07-01 John A Epps Syringe
US2939459A (en) 1957-01-11 1960-06-07 Jorge A Lazarte Tandem syringe
US3477432A (en) 1964-07-21 1969-11-11 Joseph Denman Shaw Combination mixing and injecting medical syringe
US3376999A (en) 1967-05-31 1968-04-09 Gen Dynamics Corp Packaging, mixing and dispensing apparatus
US3892311A (en) 1969-01-31 1975-07-01 Vincent R Sneider Disposable syringe kit
AT318132B (de) 1969-08-01 1974-09-25 Dentaire Ivoclar Ets Mischbehälter für die Aufnahme von miteinander reagierenden Substanzen für die Herstellung von gebrauchsfertigen pastenförmigen Dentalpräparaten
US3762540A (en) 1970-05-19 1973-10-02 Dentaire Ivoclar Ets Receptacle having at least three chambers
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3788320A (en) 1972-02-25 1974-01-29 Kendall & Co Spinal needle
US4226328A (en) 1979-04-09 1980-10-07 Baxter Travenol Laboratories, Inc. Catheterization package
US4383530A (en) 1981-06-05 1983-05-17 John Bruno Hypodermic needle and method of making needles
US4377897A (en) 1981-08-04 1983-03-29 Ocular Associates Ophthalmic needle and method for manufacturing the same
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
JPS5875563A (ja) 1981-10-30 1983-05-07 テルモ株式会社 留置カテ−テル用接続具
US4564016A (en) 1982-05-24 1986-01-14 The Board Of Trustees Of The Leland Stanford Junior University Apparatus for introducing ionized drugs into the posterior segment of the eye and method
WO1985000097A1 (fr) 1983-06-28 1985-01-17 Sterimed Gesellschaft Für Medizinischen Bedarf Mbh Appareils medicaux avec dispositif d'aide d'introduction
US4501363A (en) 1983-10-25 1985-02-26 Isbey Jr Edward K Surgical kit
NZ212899A (en) 1984-07-31 1987-10-30 Phillips Pty Ltd N J Piston operated adjustable volume dose injector for animals
US4708147A (en) 1985-02-25 1987-11-24 Haaga John R Universal biopsy needle
US4826871A (en) 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4689040A (en) 1985-04-29 1987-08-25 Thompson Robert J Tip for a phacoemulsification needle
US4689042A (en) 1985-05-20 1987-08-25 Survival Technology, Inc. Automatic medicament ingredient mixing and injecting apparatus
US4826490A (en) 1985-07-29 1989-05-02 National Research Development Corporation Safety device for hypodermic needle or the like
US4601708A (en) 1985-09-09 1986-07-22 Pavel Jordan Automatic injection for syringe needle, and assembly
US4736850A (en) 1986-10-17 1988-04-12 W. L. Gore & Associates, Inc. Endothelial cell harvesting kit
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4795432A (en) 1987-02-19 1989-01-03 Karczmer Claude M Shield assembly for hypodermic injection devices
US4804371A (en) 1987-05-06 1989-02-14 Vaillancourt Vincent L Post-injection needle sheath
DE3868298D1 (de) 1987-07-10 1992-03-19 Braun Melsungen Ag Kanuele.
DE3802158A1 (de) 1987-08-11 1989-02-23 Hoechst Ag Vorrichtung zur applikation von implantaten
US5547467A (en) 1988-01-21 1996-08-20 Massachusettes Institute Of Technology Method for rapid temporal control of molecular transport across tissue
US5066276A (en) 1988-06-21 1991-11-19 Alcon Laboratories, Inc. Method and apparatus for injecting viscous fluid into the eye to lift pre-retinal and post-retinal membrane with linear pressure control
KR0159754B1 (ko) 1988-09-23 1998-12-15 헌터 프랭크 구강 위생 측정장치
US5817075A (en) 1989-08-14 1998-10-06 Photogenesis, Inc. Method for preparation and transplantation of planar implants and surgical instrument therefor
US5164188A (en) 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5015240A (en) 1990-05-01 1991-05-14 Ian Campbell Cree Hypodermic needle shield
US5098389A (en) 1990-06-28 1992-03-24 Becton, Dickinson And Company Hypodermic needle assembly
ES2023597A6 (es) 1990-11-05 1992-01-16 Rodiera Olive Jose Javier Aguja para uso medico, en especial para funcion lumbar y anestesia regional.
US5273530A (en) 1990-11-14 1993-12-28 The University Of Rochester Intraretinal delivery and withdrawal instruments
EP0501034A1 (fr) 1991-01-30 1992-09-02 CeramOptec GmbH Dispositif de guidage illuminé
US5206267A (en) * 1991-05-09 1993-04-27 Morton Shulman Pain controlling composition and method of preparation
US5181909A (en) 1991-05-15 1993-01-26 Mcfarlane Richard H Ampule-container medical syringe and methods
DE4120173A1 (de) 1991-06-19 1992-12-24 Hoechst Ag Positiv arbeitendes strahlungsempfindliches gemisch und damit hergestelltes strahlungsempfindliches aufzeichnungsmaterial
US5312361A (en) 1991-09-13 1994-05-17 Zadini Filiberto P Automatic cannulation device
US5172807A (en) 1991-09-30 1992-12-22 Centrix, Inc. Cement mixing capsule
AU4282793A (en) 1992-04-10 1993-11-18 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University A microneedle for injection of ocular blood vessels
US5767079A (en) 1992-07-08 1998-06-16 Celtrix Pharmaceuticals, Inc. Method of treating ophthalmic disorders using TGF -β
JPH08502033A (ja) 1992-07-08 1996-03-05 セルトリックス ファーマシューティカルズ，インコーポレイテッド ＴＧＦ−βを用いる眼疾患の治療方法
US5295972A (en) 1992-08-04 1994-03-22 Metatech Corporation Hypodermic syringe with protective cap
US5279564A (en) 1992-09-11 1994-01-18 Edward Weck Incorporated Cannula retention device
US5300084A (en) 1992-11-23 1994-04-05 United States Surgical Corporation Pneumoperitoneum needle
EP0674528A4 (fr) 1992-12-02 1996-06-26 Insite Vision Inc Cyclodextrine et systeme de liberation de medicament a base de polymere.
US5681825A (en) 1993-03-15 1997-10-28 Lindqvist; Bengt Surgical method
US5399159A (en) 1993-03-30 1995-03-21 Origin Medsystems, Inc. Apparatus and method for hand-held insufflation
US5407070A (en) 1993-08-18 1995-04-18 Bascos; Christine M. One-time resealable package for needled medical devices
US5415629A (en) 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5354286A (en) 1993-12-07 1994-10-11 Survival Technology, Inc. Injection device having polyparaxylylene coated container
US5397313A (en) 1994-01-27 1995-03-14 The Kendall Company Low friction syringe
US5658256A (en) 1994-08-22 1997-08-19 Shields; Jack W. Universal sharps shield
SE9402816D0 (sv) 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
WO1996009838A1 (fr) 1994-09-28 1996-04-04 Celtrix Pharmaceuticals, Inc. PROCEDE DE TRAITEMENT DE LA DEGENERESCENCE MACULAIRE AU MOYEN DE TGF-$g(b)
US5792099A (en) 1995-02-14 1998-08-11 Decamp; Dennis Syringe and cannula for insertion of viscoelastic material into an eye and method of using same
US5779668A (en) 1995-03-29 1998-07-14 Abbott Laboratories Syringe barrel for lyophilization, reconstitution and administration
US5968022A (en) 1995-04-28 1999-10-19 Saito; Yoshikuni Medical hollow needle and method of production
USD383049S (en) 1995-06-30 1997-09-02 Fiskars Inc. Tool handle grip
US6280470B1 (en) 1995-10-20 2001-08-28 Gholam A. Peyman Intrastromal corneal modification
US5788679A (en) 1996-06-26 1998-08-04 Gravlee, Jr.; Joseph F. Phacoemulsification needle
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5911223A (en) 1996-08-09 1999-06-15 Massachusetts Institute Of Technology Introduction of modifying agents into skin by electroporation
YU58599A (sh) 1997-05-16 2000-12-28 Amgen Inc. Gelovi sa usporenim podržanim oslobađanjem
AUPO940697A0 (en) 1997-09-23 1997-10-16 Kaal, Joseph Hermes Retractable syringe
US7273458B2 (en) 1998-01-12 2007-09-25 Georgia Tech Research Corporation Method of applying acoustic energy effective to alter transport or cell viability
WO1999044899A1 (fr) 1998-03-04 1999-09-10 Medtronic, Inc. Systeme de conditionnement de dispositifs medicaux
US6309347B1 (en) 1998-03-17 2001-10-30 Fuji Photo Optical Co., Ltd. Air and water supply system for endoscopes
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6540725B1 (en) 1998-06-04 2003-04-01 Biosense Webster, Inc. Injection catheter with controllably extendable injection needle
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6936053B1 (en) 1998-07-02 2005-08-30 Jeffrey N. Weiss Ocular implant needle
US6309374B1 (en) 1998-08-03 2001-10-30 Insite Vision Incorporated Injection apparatus and method of using same
US6378526B1 (en) 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
FR2784034B1 (fr) 1998-10-01 2000-12-15 Marc Brunel Dispositif d'injection a usage unique destine a etre pre-rempli
US6219575B1 (en) 1998-10-23 2001-04-17 Babak Nemati Method and apparatus to enhance optical transparency of biological tissues
US20040141925A1 (en) * 1998-11-12 2004-07-22 Elan Pharma International Ltd. Novel triamcinolone compositions
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
JP5483789B2 (ja) 1999-01-05 2014-05-07 ザ フリンダーズ ユニバーシティ オブ サウス オーストラリア 眼障害を治療及び診断するための新規な薬物及び方法
US6699210B2 (en) 1999-04-27 2004-03-02 The Arizona Board Of Regents Glaucoma shunt and a method of making and surgically implanting the same
US6319240B1 (en) 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
FR2794650B1 (fr) 1999-06-10 2001-09-14 Marc Brunel Dispositif d'injection a usage unique
FR2801795B1 (fr) 1999-12-07 2002-07-05 Plastef Investissements Dispositif de support de securite pour une seringue et ensemble d'un tel dispositif et d'une seringue
CA2393673A1 (fr) 1999-12-10 2001-06-14 Iscience Corporation Traitement de maladies oculaires
US20010051798A1 (en) 1999-12-28 2001-12-13 Hochman Mark N. Method of performing an injection using a bi-directional rotational insertion technique
US6726676B2 (en) 2000-01-05 2004-04-27 Grieshaber & Co. Ag Schaffhausen Method of and device for improving the flow of aqueous humor within the eye
JP4372310B2 (ja) 2000-04-10 2009-11-25 ニプロ株式会社 混注用アダプター
US6622864B1 (en) 2000-06-01 2003-09-23 Osteotech, Inc. Moisture resistant package for storing sterile items
JP4187922B2 (ja) 2000-09-14 2008-11-26 テルモ株式会社 液体注入針および液体注入装置
CA2426600A1 (fr) 2000-10-31 2002-05-23 Smith & Nephew, Inc. Systeme de conditionnement et d'apport pour particules de greffe osseuse
US20030060447A1 (en) 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
US6915901B2 (en) 2000-12-11 2005-07-12 Marc Feinberg Packaging assembly for surgical use
WO2002064193A2 (fr) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Appareils a microaiguilles et fabrication
US6387078B1 (en) 2000-12-21 2002-05-14 Gillespie, Iii Richard D. Automatic mixing and injecting apparatus
US20030171722A1 (en) 2001-01-04 2003-09-11 Michel Paques Microsurgical injection and/or distending instruments and surgical method and apparatus utilizing same
EP1353617A2 (fr) 2001-01-18 2003-10-22 The Regents Of The University Of California Instrument chirurgical et methode de traitement du glaucome peu invasifs
US6378849B1 (en) * 2001-04-13 2002-04-30 General Electric Company Methods and apparatus for mounting motors
US20090088721A1 (en) 2001-04-17 2009-04-02 Eyegate Pharma S.A.S. Enhanced retinal delivery of a nucleic acid through iontophoresis
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US20030073609A1 (en) 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US6749792B2 (en) 2001-07-09 2004-06-15 Lifescan, Inc. Micro-needles and methods of manufacture and use thereof
EP1420839A4 (fr) 2001-07-24 2008-05-21 Artes Medical Inc Seringue allongee
JP2003052819A (ja) 2001-08-10 2003-02-25 Seikagaku Kogyo Co Ltd 薬剤充填注射器包装物およびその滅菌または殺菌方法
WO2003024507A2 (fr) 2001-09-19 2003-03-27 Biovalve Technologies, Inc. Microaiguilles, jeux de microaiguilles, et systemes et procedes associes
EP1471953B1 (fr) 2001-09-21 2011-02-16 Valeritas, Inc. Amenagements de micro-aiguilles activees par pression de gaz, systemes et procedes correspondants
US7429258B2 (en) 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US7569035B1 (en) 2001-11-02 2009-08-04 Meridian Medical Technologies, Inc. Automatic injector with anti-coring needle
EP1810645B1 (fr) 2001-11-22 2010-07-28 Eduard Anton Haefliger Dispositif et procédé destinés à l'exécution d'opérations ophtalmologiques
US7204823B2 (en) 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
US6821286B1 (en) 2002-01-23 2004-11-23 Cardica, Inc. System for preparing a graft vessel for anastomosis
US20050033230A1 (en) 2002-02-15 2005-02-10 Alchas Paul G. Prefillable intradermal delivery device with hidden needle and passive shielding
CN1638734A (zh) 2002-02-22 2005-07-13 参天制药株式会社 微粒结膜下给药的药物释放系统
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
CN100482288C (zh) 2002-05-16 2009-04-29 斯科特实验室公司 药物容器进入机构和方法
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
US7316676B2 (en) 2002-08-20 2008-01-08 Gholam A. Peyman Treatment of retinal detachment
DE10242984B4 (de) 2002-09-17 2010-09-23 Sanatis Gmbh Vorrichtung zum Herstellen von Gemischen aus zwei Komponenten
US7090681B2 (en) 2002-09-18 2006-08-15 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US20040106904A1 (en) 2002-10-07 2004-06-03 Gonnelli Robert R. Microneedle array patch
US6883222B2 (en) 2002-10-16 2005-04-26 Bioject Inc. Drug cartridge assembly and method of manufacture
CN101336887A (zh) 2002-12-04 2009-01-07 参天制药株式会社 结膜下给药用药物组合物
JP2004196787A (ja) 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
US8110209B2 (en) 2002-12-20 2012-02-07 Xeris Pharmaceuticals Inc. Intracutaneous injection
JP5148107B2 (ja) 2003-01-21 2013-02-20 カルメル ファルマ アクチボラゲット 膜を突き刺すための針
GB0301934D0 (en) 2003-01-28 2003-02-26 Sundar Satish Delivery apparatus and location method
US8490790B2 (en) 2003-02-24 2013-07-23 Becton Dickinson France S.A.S. Plate for holding a group of syringe body objects
US20040199130A1 (en) 2003-04-03 2004-10-07 Chornenky Victor I. Apparatus and method for treatment of macular degeneration
US7533514B2 (en) 2003-04-25 2009-05-19 Boston Scientific Scimed, Inc. Method and apparatus for automated handling of medical devices during manufacture
US7435237B2 (en) 2003-06-02 2008-10-14 Boston Scientific Scimed, Inc. Mixing syringes with breakable septums
US8403941B2 (en) 2003-06-02 2013-03-26 Abbott Medical Optics Inc. Intraocular lens and cartridge packaging with lens-loading function
EP1633250A2 (fr) 2003-06-04 2006-03-15 Georgia Tech Research Corporation Dispositif a micro-aiguille de forage
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
DE10327119A1 (de) 2003-06-13 2004-12-30 Aventis Pharma Deutschland Gmbh Kappe für Injektionsvorrichtungen
AU2004247272A1 (en) 2003-06-16 2004-12-23 Solx, Inc. Shunt for the treatment of glaucoma
PL1638468T3 (pl) 2003-06-30 2008-01-31 Alza Corp Sposób powlekania mikrowystępów do przekłuwania skóry
USD499153S1 (en) 2003-07-08 2004-11-30 Test Rite International Company, Ltd Handle for jump rope
US20050009910A1 (en) 2003-07-10 2005-01-13 Allergan, Inc. Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
CN1852700A (zh) * 2003-09-23 2006-10-25 爱尔康公司 曲安奈德和醋酸阿奈可他注射用制剂
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20090148527A1 (en) 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US20050101882A1 (en) 2003-11-12 2005-05-12 Leira Enrique C. Safety pressure device for body fluid extraction
US7967772B2 (en) 2004-01-12 2011-06-28 Iscience Interventional Corporation Injector for viscous materials
DE602005011928D1 (de) 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
SG149883A1 (en) 2004-01-23 2009-02-27 Iscience Surgical Corp Composite ophthalmic microcannula
US7678077B2 (en) 2004-02-20 2010-03-16 Boston Scientific Scimed, Inc. Variable depth injection device and method
US7361168B2 (en) * 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US20080058704A1 (en) 2004-04-29 2008-03-06 Michael Hee Apparatus and Method for Ocular Treatment
US20100173866A1 (en) 2004-04-29 2010-07-08 Iscience Interventional Corporation Apparatus and method for ocular treatment
ZA200609409B (en) 2004-04-29 2008-07-30 Iscience Interventional Corp Apparatus and method for ocular treatment
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
BRPI0509334A (pt) 2004-04-30 2007-10-16 Eyegate Pharma S A dispositivo de iontoforese ocular, que diminui as irritações
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US20050244462A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
WO2006004595A2 (fr) 2004-05-28 2006-01-12 Georgia Tech Research Corporation Procedes et dispositifs destines a un traitement thermique
US8323227B2 (en) 2004-07-02 2012-12-04 C. R. Bard, Inc. Tip configurations for a multi-lumen catheter
BRPI0513243B8 (pt) 2004-07-12 2021-05-25 Allergan Inc composições oftálmicas e respectivos usos
US7615041B2 (en) 2004-07-29 2009-11-10 Boston Scientific Scimed, Inc. Vial adaptor
US7503920B2 (en) 2004-08-11 2009-03-17 Tzony Siegal Spinal surgery system and method
US7722669B2 (en) 2004-08-13 2010-05-25 Richard Foulkes Method and insert for modifying eye color
US8114110B2 (en) 2004-09-22 2012-02-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Transseptal puncture needle and needle assemblies
US7947267B2 (en) 2004-10-08 2011-05-24 Potentia Pharmaceuticals, Inc. Viral complement control proteins for eye disorders
US7627938B2 (en) 2004-10-15 2009-12-08 Board Of Regents, The Univeristy Of Texas System Tapered hollow metallic microneedle array assembly and method of making and using the same
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US8262715B2 (en) 2004-11-23 2012-09-11 Eye Delivery System, Llc Medical device and method for temperature control and treatment of the eye and surrounding tissues via magnetic drug therapy
WO2006058189A2 (fr) 2004-11-23 2006-06-01 Wong Jr Edward K Dispositif medical pour reguler la temperature et traiter l'oeil et les tissus environnants
US20060173418A1 (en) 2004-12-13 2006-08-03 Arrow International, Inc. Loss of resistance syringe
US20060169664A1 (en) 2004-12-28 2006-08-03 Holopack International Corp. Vial for filling a syringe
US7803142B2 (en) 2005-02-02 2010-09-28 Summit Access Llc Microtaper needle and method of use
US7921992B2 (en) 2005-11-14 2011-04-12 Pactiv Corporation Container having internal reservoir
TW200640443A (en) 2005-02-23 2006-12-01 Alcon Inc Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
US20060233858A1 (en) 2005-03-08 2006-10-19 Allergan, Inc. Systems and methods providing targeted intraocular drug delivery
AU2006223131A1 (en) 2005-03-11 2006-09-21 Alcon, Inc. RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
EP1868661A1 (fr) 2005-04-08 2007-12-26 SurModics, Inc. Implants à libération prolongée pour l'apport sous-rétinien
US7645264B2 (en) 2005-04-11 2010-01-12 Becton, Dickinson And Company Injection device with secondary reservoir
US7722581B2 (en) 2005-04-11 2010-05-25 Gholam A. Peyman Crystalline lens drug delivery
EP1876987A4 (fr) 2005-04-26 2009-11-18 Biolase Tech Inc Procedes de traitement de maladies de l'oeil
US20060259008A1 (en) 2005-04-27 2006-11-16 Allergan, Inc. Apparatus and methods useful for intravitreal injection of drugs
CN100463668C (zh) 2005-05-09 2009-02-25 凌沛学 可逆性热凝胶化水性药物组合物
WO2006128034A1 (fr) 2005-05-25 2006-11-30 Georgia Tech Research Corporation Microaiguilles et methodes de microperfusion
EP1893130A4 (fr) 2005-06-17 2015-08-26 Georgia Tech Res Inst Microstructures revetues et procede de fabrication de celles-ci
CN100430069C (zh) 2005-07-28 2008-11-05 凌沛学 一种中药及其复方的可逆性热凝胶化水性药物组合物
WO2007038687A2 (fr) 2005-09-27 2007-04-05 Aciont, Inc. Administration oculaire d'agents immunosuppresseurs
US20070093877A1 (en) 2005-10-26 2007-04-26 Beecham Michael C System for maintaining normal health of retinal cells and promoting regeneration of retinal cells
US20070123947A1 (en) 2005-11-30 2007-05-31 Wenger William K Medical device packaging system
CN101351239A (zh) 2005-12-23 2009-01-21 导管治疗有限公司 冲洗导管
EP1978892B1 (fr) 2006-01-17 2017-11-15 Novartis Ag Dispositif de traitement d'administration de medicament
US20070185495A1 (en) 2006-01-30 2007-08-09 Howmedica International S. De R. L. Plug-in syringe stand
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US7918814B2 (en) 2006-05-02 2011-04-05 Georgia Tech Research Corporation Method for drug delivery to ocular tissue using microneedle
US20070270768A1 (en) 2006-05-17 2007-11-22 Bruno Dacquay Mechanical Linkage Mechanism For Ophthalmic Injection Device
US20070270745A1 (en) 2006-05-18 2007-11-22 Camran Nezhat Vacuum actuated tissue lifting device
USD598543S1 (en) 2006-06-13 2009-08-18 Angiomed Gmbh & Co. Medizintechnik Kg Handle for a medical delivery device
US8668676B2 (en) 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8974511B2 (en) 2010-11-15 2015-03-10 Aquesys, Inc. Methods for treating closed angle glaucoma
US8852137B2 (en) 2010-11-15 2014-10-07 Aquesys, Inc. Methods for implanting a soft gel shunt in the suprachoroidal space
US8663303B2 (en) 2010-11-15 2014-03-04 Aquesys, Inc. Methods for deploying an intraocular shunt from a deployment device and into an eye
US20080152694A1 (en) 2006-07-20 2008-06-26 Neurosystec Corporation Devices, Systems and Methods for Ophthalmic Drug Delivery
US20080097335A1 (en) 2006-08-04 2008-04-24 Allergan, Inc. Ocular implant delivery assemblies
US20080058717A1 (en) 2006-09-04 2008-03-06 Spector David M Oral cavity liquid delivery system including pre-angled needle guidance assembly and method for using the same
US7998108B2 (en) 2006-09-12 2011-08-16 Psivida Us, Inc. Injector apparatus and method of use
US8944069B2 (en) 2006-09-12 2015-02-03 Vidacare Corporation Assemblies for coupling intraosseous (IO) devices to powered drivers
US20080097346A1 (en) 2006-09-19 2008-04-24 Alcon, Inc. Trocar cannula
US20080097390A1 (en) 2006-09-27 2008-04-24 Alcon Manufacturing, Ltd. Spring actuated delivery system
AU2007319383A1 (en) 2006-11-10 2008-05-22 Glaukos Corporation Uveoscleral shunt and methods for implanting same
CA2670990A1 (fr) 2006-12-01 2008-06-12 Allergan, Inc. Procede pour determiner des emplacements oculaires optimaux pour des systemes d'administration de medicament
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
RU2344767C2 (ru) 2006-12-18 2009-01-27 Наталья Александровна Уракова Способ внутриартериальной инъекции по а.л. уракову
TWI457336B (zh) * 2006-12-28 2014-10-21 Kinex Pharmaceuticals Llc 調節激酶級聯之組成物及方法
JP5201744B2 (ja) 2007-01-09 2013-06-05 フォヴェア ファルマシューティカル 眼内注射装置
US20080177239A1 (en) 2007-01-18 2008-07-24 Yong Li Trocar cannula system
DE102007018696A1 (de) 2007-04-18 2008-10-23 Sanofi-Aventis Deutschland Gmbh Injektionsvorrichtung zur Abgabe eines Medikaments
USD590690S1 (en) 2007-05-24 2009-04-21 Domino S.P.A. Handlebar hand grip
US20090030381A1 (en) 2007-07-23 2009-01-29 Lind Casey J Arced Hypodermic Needle
CA2695996A1 (fr) 2007-08-16 2009-02-19 East Carolina University Systemes de seringue d'injection intelligente fournissant un retour utilisateur en temps reel
CA2639322C (fr) 2007-09-07 2016-11-08 Becton, Dickinson And Company Collet d'aiguille pour stylo injecteur presentant une surface de contact accrue
KR20100058620A (ko) 2007-09-07 2010-06-03 큐엘티 플러그 딜리버리, 인코포레이티드 눈물 임플랜트용 삽입 및 적출 기구
US20090076463A1 (en) 2007-09-17 2009-03-19 Jurg Attinger Trocar Cannula
US20090081277A1 (en) 2007-09-21 2009-03-26 Allergan, Inc. Pharmaceutical formulations and methods for treating ocular conditions
US8631935B2 (en) 2009-06-03 2014-01-21 Medline Industries, Inc. Catheter tray, packaging system, and associated methods
US8448786B2 (en) 2009-06-30 2013-05-28 Medline Industries, Inc. Catheter tray, packaging system, instruction insert, and associated methods
US8602959B1 (en) 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
JP2009183441A (ja) 2008-02-06 2009-08-20 Ken Kondo 静脈留置針組立体
KR20100135748A (ko) * 2008-02-21 2010-12-27 센주 세이야꾸 가부시키가이샤 아쥬반트로서의 안과용 ｎｓａｉｄ
US20100152646A1 (en) 2008-02-29 2010-06-17 Reshma Girijavallabhan Intravitreal injection device and method
CN101959519B (zh) * 2008-03-11 2013-03-20 爱尔康研究有限公司 用于玻璃体内注射的低粘度、高度絮凝的曲安奈德混悬液
US20090259180A1 (en) 2008-04-11 2009-10-15 Jong Soo Choi Injection method using injector with length-adjustable needle and injection apparatus using the same
US20090287161A1 (en) 2008-05-15 2009-11-19 Allergan, Inc Metered, multiple dose/aliquot syringe
US20090312782A1 (en) 2008-06-13 2009-12-17 Maxwell Choongwon Park Method and apparatus for repairing tendons
US9022940B2 (en) 2008-07-18 2015-05-05 Joseph H. Meier Handheld imaging devices and related methods
US8821870B2 (en) 2008-07-18 2014-09-02 Allergan, Inc. Method for treating atrophic age related macular degeneration
WO2010011270A2 (fr) 2008-07-21 2010-01-28 Smiths Medical Asd, Inc. Ensemble plateau
CA2735289A1 (fr) 2008-08-30 2010-03-04 Sanofi-Aventis Deutschland Gmbh Cartouche et systeme d'aiguille associe
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
US7678078B1 (en) 2008-10-21 2010-03-16 KMG Pharma LLC Intravitreal injection device, system and method
WO2010054660A1 (fr) 2008-11-11 2010-05-20 Herlev Hospital Système à double canule pour une aiguille d'anesthésie
EP2389138B1 (fr) 2008-12-05 2021-09-15 Ivantis, Inc. Appareils de placement d'implants oculaires dans l'oeil
WO2010067319A2 (fr) 2008-12-09 2010-06-17 Nanopass Technologies Ltd. Dispositif pour injecter un fluide à partir d'un raccord de micro-aiguille comportant un élément d'insertion réduisant l'espace mort
US8545554B2 (en) 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
US8425473B2 (en) 2009-01-23 2013-04-23 Iscience Interventional Corporation Subretinal access device
ES2378012B1 (es) 2009-01-29 2013-02-12 Innova Salud Desarrollos Sanitarios S.L. Dispositivo para la administración de productos inyectables con caudal controlado.
US8192408B2 (en) 2009-02-10 2012-06-05 Psivida Us, Inc. Ocular trocar assembly
US8057483B2 (en) 2009-02-14 2011-11-15 Ocular Transplantation Llc Subretinal implantation instrument
CN201356711Y (zh) 2009-02-23 2009-12-09 徐学农 玻璃体腔冲洗针头
EP2403564B1 (fr) 2009-03-02 2018-04-25 Sanofi-Aventis Deutschland GmbH Dispositif médical d'administration avec éléments d'appui escamotables pour doigts
WO2010100240A1 (fr) 2009-03-05 2010-09-10 Sanofi-Aventis Deutschland Gmbh Ensemble aiguille
CA2753982A1 (fr) 2009-03-05 2010-09-10 Sanofi-Aventis Deutschland Gmbh Unite d'aiguille
EP2403570B1 (fr) 2009-03-05 2015-07-15 Sanofi-Aventis Deutschland GmbH Dispositif d'administration de médicaments
CA2753939A1 (fr) 2009-03-05 2010-09-10 Sanofi-Aventis Deutschland Gmbh Dispositif d'administration de medicament au moyen d'une aiguille retractable
EP2403571A1 (fr) 2009-03-06 2012-01-11 Sanofi-Aventis Deutschland GmbH Dispositif de distribution de médicament muni d'une aiguille rétractable
US8287494B2 (en) 2009-03-23 2012-10-16 Colin Ma Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye
SE0900371A1 (sv) 2009-03-24 2010-09-25 Istvan Bartha Anordning för distribution av flytande läkemedel
US20120029360A1 (en) 2009-04-15 2012-02-02 Koninklijke Philips Electronics N.V. Needle with integrated fibers in the cutting facets of the bevel
WO2010125551A2 (fr) 2009-04-29 2010-11-04 Janisys Limited Dispositif et appareil à micro-aiguilles et procédé d'application d'un élément à micro-aiguilles sur un site de la peau d'un sujet
SG176067A1 (en) 2009-05-15 2011-12-29 Iscience Interventional Corp Methods and apparatus for sub-retinal catheterization
US8795226B2 (en) 2009-06-25 2014-08-05 Sanofi-Aventis Deutschland Gmbh Cannula assembly for co-delivery of medicaments
RU2428956C2 (ru) 2009-07-13 2011-09-20 Александр Дмитриевич Ромащенко Способ лечения атрофии зрительного нерва посредством трансплантации аутологичных стволовых клеток
US8535333B2 (en) 2009-07-29 2013-09-17 Transcend Medical, Inc. Ocular implant applier and methods of use
DK2464400T3 (en) 2009-08-12 2015-05-04 Sanofi Aventis Deutschland Cap for a portable medical feeder and such a medical feeder
US8221753B2 (en) * 2009-09-30 2012-07-17 Tracon Pharmaceuticals, Inc. Endoglin antibodies
WO2011023738A1 (fr) 2009-08-28 2011-03-03 Sanofi-Aventis Deutschland Gmbh Kit de montage pour la préparation d’une seringue pré-remplie
US20130041265A1 (en) 2009-09-21 2013-02-14 Ron Sostek Methods and apparatus for introducing cells at a tissue site
WO2011057065A1 (fr) 2009-11-06 2011-05-12 The Uab Research Foundation Appareils et procédés pour administrer des substances dans l'oeil interne
WO2011057334A1 (fr) 2009-11-11 2011-05-19 Unitract Syringe Pty Ltd Seringue clinique
EP2918302B1 (fr) 2009-12-22 2018-11-14 UNL Holdings LLC Seringue rétractable à rendement amélioré et système de verrouillage
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
WO2011084504A1 (fr) 2010-01-05 2011-07-14 Allergan, Inc. Seringue comprenant deux plongeurs pourvus de moyens de verrouillage
US20110213317A1 (en) 2010-03-01 2011-09-01 Chen David E-Bin Cannula for intraocular surgery
EP2364740A1 (fr) 2010-03-09 2011-09-14 Sanofi-Aventis Deutschland GmbH Agencement pour transférer une translation de moyen de commande à un piston
GB201004102D0 (en) 2010-03-12 2010-04-28 Liversidge Barry P Syringe barrels and handling systems
US9408746B2 (en) 2010-03-31 2016-08-09 Ocuject, Llc Device and method for intraocular drug delivery
US9320647B2 (en) 2010-03-31 2016-04-26 Ocuject, Llc Device and method for intraocular drug delivery
US8430862B2 (en) 2010-04-08 2013-04-30 KMG Pharma LLC Subconjunctival agent delivery apparatus, system and method
US8652118B2 (en) 2010-04-08 2014-02-18 Kmg Pharma, Llc Sub-mucosal agent delivery, apparatus, system and method
US8574217B2 (en) 2010-04-08 2013-11-05 Kmg Pharma, Llc Sub-mucosal agent delivery method for the eye
TWI556807B (zh) 2010-05-04 2016-11-11 Unitract Syringe Pty Ltd Syringe syringe adapter and syringe assembly
US8632589B2 (en) 2010-05-04 2014-01-21 Abbott Medical Optics Inc. IOL insertion system with semi-automatic trailing haptic configuration management
US8932258B2 (en) 2010-05-14 2015-01-13 C. R. Bard, Inc. Catheter placement device and method
US8545430B2 (en) 2010-06-09 2013-10-01 Transcend Medical, Inc. Expandable ocular devices
EP2600923B1 (fr) 2010-06-10 2018-08-08 Anthony J. Colantonio Appareil et procédé pour insérer en toute sécurité une aiguille d'introduction dans un espace péridural
BR112012033388A2 (pt) 2010-07-02 2016-11-22 Alcon Res Ltd compostos para o tratamento de distúrbios e doenças de segmento posterior
KR101180032B1 (ko) 2010-07-12 2012-09-05 인싸이토(주) 외형 조절이 가능한 중공형 마이크로니들의 제조방법
TW201216948A (en) 2010-07-19 2012-05-01 Sanofi Aventis Deutschland Medicament cartridges with non-standard dimensions
JP2013538655A (ja) 2010-09-30 2013-10-17 エボニック コーポレイション 薬剤含有体を目標部位に送達するためのドラッグデリバリブレード及び方法
WO2012041870A1 (fr) 2010-10-01 2012-04-05 Sanofi-Aventis Deutschland Gmbh Ensemble aiguille comprenant un mécanisme de libération
EP2438939A1 (fr) 2010-10-08 2012-04-11 Sanofi-Aventis Deutschland GmbH Agencement pour coupler un piston avec une seringue ou un butoir
CN104758118B (zh) 2010-10-15 2018-04-06 科尼尔赛德生物医学公司 用于进入眼睛的装置
US20120101475A1 (en) 2010-10-21 2012-04-26 Meridian Medical Technologies, Inc. High Efficiency Auto-Injector
CA2813473A1 (fr) 2010-10-25 2012-05-03 Sanofi-Aventis Deutschland Gmbh Dispositif pour regler la profondeur de penetration d'une aiguille d'injection
EP2446866A1 (fr) 2010-11-02 2012-05-02 Fovea Pharmaceuticals Appareil pour injection dans un oeil
US8747365B2 (en) 2010-11-03 2014-06-10 Sanofi-Aventis Deutschland Gmbh Needle cannula containing medicament
US9241701B2 (en) 2010-11-11 2016-01-26 Depuy Mitek, Inc. Cannula system and method for partial thickness rotator cuff repair
JP5704389B2 (ja) 2010-11-29 2015-04-22 ニプロ株式会社 医療用中空針および医療用中空針の製造方法
US8608710B2 (en) 2010-12-09 2013-12-17 Becton Dickinson & Company Pen needle assembly with different gauge needle cannulas
US9968337B2 (en) 2010-12-20 2018-05-15 Cook Medical Technologies Llc Coring tissue biopsy needle and method of use
JP2014514259A (ja) * 2011-03-02 2014-06-19 アクイラス ファーマシューティカルズ， インコーポレイテッド 疼痛および他の障害の処置のための化合物および方法
EP2686446A4 (fr) * 2011-03-15 2014-08-27 Univ Utah Res Found Procédés de diagnostic et de traitement de la maculopathie vasculaire associée et des symptomes correspondants
EP2500002A1 (fr) 2011-03-17 2012-09-19 Sanofi-Aventis Deutschland GmbH Appareil pour injection intraoculaire
USD667111S1 (en) 2011-03-17 2012-09-11 Surgical Innovations Limited Handle for surgical instrument
EP2510911A1 (fr) 2011-04-13 2012-10-17 Sanofi-Aventis Deutschland GmbH Appareil pour injection intraoculaire
EP2510902A1 (fr) 2011-04-15 2012-10-17 Sanofi-Aventis Deutschland GmbH Dispositif d'injection intraoculaire
EP2514461A1 (fr) 2011-04-20 2012-10-24 Sanofi-Aventis Deutschland GmbH Ensemble d'aiguille pour dispositif médical
EP2514684A1 (fr) 2011-04-20 2012-10-24 Becton Dickinson France Conditionnement pour récipients médicaux
EP2522318A1 (fr) 2011-05-12 2012-11-14 Sanofi-Aventis Deutschland GmbH Guide device for intraocular injection
WO2012162459A1 (fr) 2011-05-26 2012-11-29 Pepose Jay Dispositif et procédé pour administrer des médications oculaires
EP2540261A1 (fr) 2011-06-30 2013-01-02 Sanofi-Aventis Deutschland GmbH Dispositif d'administration intra-oculaire de médicaments
CN103781506B (zh) 2011-08-05 2016-08-31 尤尼特拉克特注射器私人有限公司 在药物至目标位置的给药中使用的套管及制造套管的方法
US9339609B2 (en) 2011-09-13 2016-05-17 Sanofi-Aventis Deutschland Gmbh Injection device
EP2574355A1 (fr) 2011-09-27 2013-04-03 Sanofi-Aventis Deutschland GmbH Conditionnement pour dispositif d'administration de médicaments
EP2578260A1 (fr) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Appareil pour injection intraoculaire
EP2578190A1 (fr) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Dispositif d'injection intraoculaire
EP2578191A1 (fr) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Appareil pour injection intraoculaire
EP2578189A1 (fr) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Appareil pour injection intraoculaire
EP2586407A1 (fr) 2011-10-31 2013-05-01 Sanofi-Aventis Deutschland GmbH Dispositif d'aide pour injection intraoculaire
EP2596826A1 (fr) 2011-11-24 2013-05-29 Sanofi-Aventis Deutschland GmbH Seringue de sécurité
EP2601988A1 (fr) 2011-12-08 2013-06-12 Sanofi-Aventis Deutschland GmbH Support de seringue
KR20140105457A (ko) 2011-12-08 2014-09-01 유니트랙트 시린지 피티와이 엘티디 정확한 투여량 제어 메커니즘 및 약물 전달 주사기
EP2601990A1 (fr) 2011-12-08 2013-06-12 Sanofi-Aventis Deutschland GmbH Support de seringue
EP2601992A1 (fr) 2011-12-08 2013-06-12 Sanofi-Aventis Deutschland GmbH Support de seringue
BR112014012522A2 (pt) 2011-12-15 2017-06-06 Sanofi Aventis Deutschland método para encher um reservatório, reservatório e conjunto para encher um reservatório
ES2533576T3 (es) 2011-12-30 2015-04-13 Q-Med Ab Cánula sin hematomas
AU344164S (en) 2012-02-02 2012-09-04 Terumo Corp Safety device for indwelling needle
EP2626096A1 (fr) 2012-02-10 2013-08-14 Sanofi-Aventis Deutschland GmbH Dispositif d'administration de médicaments doté d'un mécanisme de retrait de l'ensemble formant aiguille
EP2818190B1 (fr) 2012-02-20 2016-11-02 Terumo Kabushiki Kaisha Corps de conditionnement pour dispositif médical
WO2013126498A1 (fr) 2012-02-22 2013-08-29 Schachar Ira H Dispositif et méthode destinés à traiter le décollement de la rétine et autres maladies de l'œil
US20150037422A1 (en) * 2012-02-22 2015-02-05 Trustees Of Tufts College Compositions and methods for ocular delivery of a therapeutic agent
US9050415B2 (en) 2012-02-23 2015-06-09 Unitract Syringe Pty Ltd Devices for targeted delivery of therapeutic implants
USD672506S1 (en) 2012-02-28 2012-12-11 Idea Village Products, Inc. Exfoliating device
WO2013127813A1 (fr) 2012-02-29 2013-09-06 Sanofi-Aventis Deutschland Gmbh Dispositif d'extraction destiné à une extraction unique d'un médicament hors d'un récipient
AU2013232259B2 (en) 2012-03-12 2017-10-19 Unitract Syringe Pty Ltd Fill-finish cartridges for sterile fluid pathway assemblies and drug delivery devices incorporating fill-finish cartridges
EP2641629A1 (fr) 2012-03-22 2013-09-25 Sanofi-Aventis Deutschland GmbH Dispositif d'injection avec dispositif de réduction de la douleur au site d'injection
US9421129B2 (en) 2012-04-02 2016-08-23 Ocuject, Llc Intraocular delivery devices and methods therefor
US9833523B2 (en) 2012-04-24 2017-12-05 The Ohio State University Pharmacokinetic determination of intravitreal agents
US9889248B2 (en) 2012-05-21 2018-02-13 Baxalta GmbH Syringe storage tray
US9956341B2 (en) 2012-07-03 2018-05-01 Milestone Scientific, Inc. Drug infusion with pressure sensing and non-continuous flow for identification of and injection into fluid-filled anatomic spaces
US8727117B2 (en) 2012-07-16 2014-05-20 Becton, Dickinson And Company Package for syringe
US10201655B2 (en) 2012-08-13 2019-02-12 The Brigham And Women's Hospital, Inc. Methods and devices for inserting a needle
EP2887982B1 (fr) 2012-08-27 2022-11-23 Clearside Biomedical, Inc. Appareil d'administration de médicaments à l'aide de micro-aiguilles
USD715125S1 (en) 2012-10-08 2014-10-14 The Ames Companies, Inc. Grip
KR20210133321A (ko) * 2012-11-08 2021-11-05 클리어사이드 바이오메디컬, 인코포레이드 인간 대상체에서 안구 질병을 치료하기 위한 방법 및 장치
US9022968B2 (en) 2013-01-08 2015-05-05 University Of South Florida Auto-regulation system for intraocular pressure
AU2014236455B2 (en) 2013-03-14 2018-07-12 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
USD740098S1 (en) 2013-03-19 2015-10-06 Tong Yah Electronic Technology Co., Ltd. Vehicular handle
US9987163B2 (en) 2013-04-16 2018-06-05 Novartis Ag Device for dispensing intraocular substances
CA3121759C (fr) 2013-05-03 2024-01-02 Clearside Biomedical, Inc. Appareil et methodes d'injection oculaire
EP3003454B1 (fr) 2013-06-03 2020-01-08 Clearside Biomedical, Inc. Appareil pour une administration de médicament à l'aide de multiples réservoirs
JP6594869B2 (ja) 2013-08-02 2019-10-23 テル ハショメール メディカル リサーチ インフラストラクチュアー アンド サービス エルティーディー． 目に組成物を輸送するためのデバイス
EP3030293A4 (fr) 2013-08-07 2017-03-15 Unitract Syringe Pty Ltd Adaptateurs de raccord luer pour seringues
CN105555342A (zh) 2013-08-07 2016-05-04 尤尼特拉克特注射器公司 用于可伸缩针注射器的鲁尔连接适配器
USD718602S1 (en) 2013-09-09 2014-12-02 Midwest Tool And Cutlery Company Hand grip for hand tools
USD713958S1 (en) 2013-12-05 2014-09-23 Becton, Dickinson And Company Pen needle outer cover
WO2015095772A2 (fr) 2013-12-20 2015-06-25 Emory University Préparations et procédés servant à introduire de manière ciblée des agents thérapeutiques dans l'œil
USD726908S1 (en) 2014-02-06 2015-04-14 St. Jude Medical, Cardiology Division, Inc. Catheter handle
WO2015195842A1 (fr) 2014-06-17 2015-12-23 Clearside Biomedical, Inc. Procédés et dispositifs de traitement de troubles oculaires postérieurs
MX2016017028A (es) 2014-06-20 2017-08-07 Clearside Biomedical Inc Canula de diametro variable y metodos para el control de la profundidad de insercion para administracion de medicamentos.
EP3193829B1 (fr) 2014-09-19 2021-12-08 Oxular Limited Compositions médicamenteuses ophtalmiques
US11096822B2 (en) 2014-09-19 2021-08-24 Oxular Limited Ophthalmic delivery device
USD750223S1 (en) 2014-10-14 2016-02-23 Clearside Biomedical, Inc. Medical injector for ocular injection
AU2017206114A1 (en) 2016-01-08 2018-08-02 Clearside Biomedical, Inc. Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
WO2017120600A1 (fr) 2016-01-08 2017-07-13 Clearside Biomedical, Inc. Compositions et méthodes de traitement de la dégénérescence maculaire humide liée à l'âge
WO2017139375A1 (fr) 2016-02-10 2017-08-17 Clearside Biomedical, Inc. Kit d'injection oculaire, conditionnement et procédés d'utilisation
US20190133933A1 (en) 2016-04-29 2019-05-09 Clearside Biomedical, Inc. Formulations and methods for reduction of intraocular pressure
CA3062845A1 (fr) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systemes et methodes pour l'administration de medicaments par voie ophtalmique

Also Published As

Publication number Publication date
IL238432B (en) 2020-05-31
US9636332B2 (en) 2017-05-02
US20190240208A1 (en) 2019-08-08
EP2916827B1 (fr) 2020-06-10
EP3721872A1 (fr) 2020-10-14
HK1213192A1 (zh) 2016-06-30
US20180028516A1 (en) 2018-02-01
IL238432A0 (en) 2015-06-30
JP2022119912A (ja) 2022-08-17
CA2890471A1 (fr) 2014-05-15
EP2916827A4 (fr) 2016-12-07
JP2018090632A (ja) 2018-06-14
CN110893188A (zh) 2020-03-20
US20160206628A1 (en) 2016-07-21
US20210260047A1 (en) 2021-08-26
MX2015005839A (es) 2015-12-17
BR112015010566A2 (pt) 2017-07-11
AU2013342275A1 (en) 2015-05-14
US20160213662A1 (en) 2016-07-28
US9572800B2 (en) 2017-02-21
EA201590902A1 (ru) 2016-02-29
US20170333416A1 (en) 2017-11-23
KR20210032571A (ko) 2021-03-24
JP7576061B2 (ja) 2024-10-30
MX2020005126A (es) 2022-01-27
CN104884049A (zh) 2015-09-02
CA3121763A1 (fr) 2014-05-15
CA3240136A1 (fr) 2014-05-15
JP2020033381A (ja) 2020-03-05
US20200383965A1 (en) 2020-12-10
JP2015535293A (ja) 2015-12-10
EA034963B1 (ru) 2020-04-13
WO2014074823A1 (fr) 2014-05-15
PH12015500986A1 (en) 2015-08-03
US9931330B2 (en) 2018-04-03
KR20150083117A (ko) 2015-07-16
US20180092897A1 (en) 2018-04-05
EP2916827A1 (fr) 2015-09-16
KR102467714B1 (ko) 2022-11-16
KR20210133321A (ko) 2021-11-05
US20180325884A1 (en) 2018-11-15
JP6487848B2 (ja) 2019-03-20
ES2813869T3 (es) 2021-03-25
CA2890471C (fr) 2021-07-27
JP7082599B2 (ja) 2022-06-08
AU2017272182A1 (en) 2017-12-21
AU2013342275B2 (en) 2017-11-09
US20150258120A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
HK1213192A1 (zh) 用於在人類受試者中治療眼部疾病的方法和裝置
HUS2300008I1 (hu) Bispecifikus anti-VEGF/anti-ANG-2 antitestek és ezek alkalmazása szemészeti érbetegségek kezelésében
IL261768B (en) Devices and methods for tissue treatment
HK1203478A1 (en) Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
HK1209195A1 (en) Contact lens use in the treatment of an ophthalmologic condition
EP2890440A4 (fr) Dispositifs et procédés pour le traitement d'une maladie vasculaire
EP2879617A4 (fr) Dispositifs et méthodes de traitement d'occlusion de l'artère ophtalmique
PL2701645T3 (pl) Urządzenie do leczenia i/lub zapobiegania chorobom rogówki
IL231374A (en) Use of epa and dha to treat eye disease
IL245738A0 (en) Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1212225A1 (en) Therapeutic formulation and methods of treatment
EP2949651A4 (fr) Benzothiazoles substitués et leurs appllications thérapeutiques pour le traitement de maladies humaines
EP3013425A4 (fr) Traitement et diagnostic d'une maladie oculaire
EP2789289A4 (fr) Dispositif endoscopique et dispositif de traitement
EP2709632A4 (fr) Compositions et procédés pour le traitement de maladies de la peau
IL242694B (en) A subpopulation of monocytes of human origin for the treatment of eye diseases
EP2838509A4 (fr) Formulations et procédés pour le traitement de maladies inflammatoires de la peau
HK1219654A1 (zh) 用於治療眼科疾病和病症的方法
IL239078A0 (en) Protein for use in the treatment of eye diseases
HK1209073A1 (en) Plod-2 stimulators and their use in the treatment of skin plod-2
EP2970152A4 (fr) Préparation et procédé d'utilisation pour traiter des maladies respiratoires
GB201214541D0 (en) Skin treatment formulation, and use thereof